Precision AQ
Julianna Kula, PharmD, BCOPSenior Vice President
Julianna Kula is a board-certified oncology clinical pharmacist with more than eighteen years of clinical experience. Prior to joining Precision AQ in 2022, she worked at the US Oncology Network and Rocky Mountain Cancer Centers, where she provided clinical pharmacist expertise to support the safe and appropriate delivery of oncology medications, including radiopharmaceuticals. She served as a voting member of the Rocky Mountain Cancer Centers Pharmacy and Therapeutics (P&T) and Research Committees and contributed to the onboarding and operationalization of Lutathera as both an investigational and commercial product. Earlier in her career, she was a pediatric oncology clinical pharmacist at Stanford Children’s Hospital, where she later served as the oncology investigational drug pharmacist and participated in multiple research consortia, including the Children’s Oncology Group, St. Jude’s Research Consortium, and the Pediatric Brain Tumor Consortium.
Insights from Julianna Kula, PharmD, BCOP
Commercialization & Access | White Paper
Challenges and Opportunities for Radiopharmaceutical Commercialization